Although potent inhibitors directly targeting HIF-1α pathways against hypoxic tumors are still limited, chloramphenicol, an inexpensive and excellent bactericidal antibiotic, has been found to inhibit HIF-1α accumulation in a concentration-dependent manner in NSCLC (113). The gene discussed is HIF1A; the disease is non-small cell lung carcinoma.